Verona Pharma plc

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) VRNA

Report date

9/30/2025

Quarter

2025 Q3

Filed

1/15/2026

Shares

4,283,462

Value ($000)

457,088

Weight

27.8%

2025 Q3 - 2025 Q3 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	1/15/2026	457,088	28%	4,283,462	9/30/2025